The induction of a different sensitivity pattern depending on the specific KRAS mutation has been studied in the preclinical scenario by generation of NSCLC cell lines overexpressing the three most common amino acid substitutions (G12C, G12V and G12D) leading to the KRAS-mutated proteins [75]. This evidence concerns the gene KRAS and non-small cell lung carcinoma.